CBP and histone deacetylase inhibition enhance the transactivation potential of the HOXB7 homeodomain-containing protein
- 8 July 1999
- journal article
- Published by Springer Nature in Oncogene
- Vol. 18 (27) , 4007-4014
- https://doi.org/10.1038/sj.onc.1202776
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 54 references indexed in Scilit:
- Developmental functions of mammalian Hox genesMolecular Human Reproduction, 1997
- Regulation of NF-κB by Cyclin-Dependent Kinases Associated with the p300 CoactivatorScience, 1997
- The CBP co-activator is a histone acetyltransferaseNature, 1996
- The Transcriptional Coactivators p300 and CBP Are Histone AcetyltransferasesPublished by Elsevier ,1996
- Extra specificity from extradenticle: the partnership between HOX and PBX/EXD homeodomain proteinsTrends in Genetics, 1996
- A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1ANature, 1996
- A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear ReceptorsCell, 1996
- Pbx proteins display hexapeptide-dependent cooperative DNA binding with a subset of Hox proteins.Genes & Development, 1995
- Phosphorylated CREB binds specifically to the nuclear protein CBPNature, 1993
- Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene productCell, 1991